Inventor · disambiguated record
Timothy L. Mcallister
Also filed as: MCALLISTER TIMOTHY · MCALLISTER TIMOTHY L
16 granted patents·6 pending applications·511 citations·filing 1991–2011
93Inventor score
Top patents by PatentIndex Score
22 records- 0197US6207822B1Process for the synthesis of azetidinonesSCHERING CORP·Filed 1999·Granted Mar 27, 2001·163 cites·17 claims
- 0295US5306817AProcess for the stereospecific synthesis of azetidinonesSCHERING CORP·Filed 1992·Granted Apr 26, 1994·92 cites·7 claims
- 0394US6093812AProcess for the stereospecific synthesis of azetidinonesSCHERING CORP·Filed 1994·Granted Jul 25, 2000·61 cites·8 claims
- 0491US6627757B2Enantioselective synthesis of azetidinone intermediate compoundsSCHERING CORP·Filed 2002·Granted Sep 30, 2003·62 cites·20 claims
- 0591US5728827AProcess for the synthesis of azetidinonesSCHERING CORP·Filed 1994·Granted Mar 17, 1998·59 cites·12 claims
- 0691US5561227AProcess for the stereospecific synthesis of azetidinonesSCHERING CORP·Filed 1994·Granted Oct 1, 1996·58 cites·7 claims
- 0781US7910775B2Synthesis of 2-Hydroxy-N,N-dimethyl-3-[[2-[[1(R)-(5-methyl-2-furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]amino]benzamideSCHERING CORP·Filed 2008·Granted Mar 22, 2011·4 cites·6 claims
- 0880US7462740B2Synthesis of 2-hydroxy-n,n-dimethyl-3-[[2-[[1(r)-(5-methyl-2-furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]amino]benzamideSCHERING CORP·Filed 2006·Granted Dec 9, 2008·4 cites·11 claims
- 0976US8207221B2Crystalline polymorphs of a CXC-chemokine receptor ligandHU MENGWEI·Filed 2008·Granted Jun 26, 2012·2 cites·5 claims
- 1071US7071342B2Synthesis of 2-hydroxy-N,N-dimethyl-3-[ [2-[1 (R)-(5-methyl-2-furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]aminobenzamideSCHERING CORP·Filed 2004·Granted Jul 4, 2006·5 cites·59 claims
- 1157US2006135755A1Process for the synthesis of azetidinonesSCHERING CORP·Filed 2005·Application pending·0 cites
- 1254US8383810B2Process for the synthesis of azetidinonesMERCK SHARP & DOHME·Filed 2011·Granted Feb 26, 2013·0 cites·32 claims
- 1353US7745626B2Stereoselective alkylation of chiral 2-methyl-4-protected piperazinesSCHERING CORP·Filed 2005·Granted Jun 29, 2010·0 cites·5 claims
- 1451US2011144327A1Process for the synthesis of azetidinonesSCHERING CORP·Filed 2011·Application pending·0 cites
- 1549US2011124867A1Process and intermediates for the Synthesis of heterocyclic Substituted Piperazines with CXCR3 Antagonist ActivitySCHERING CORP·Filed 2008·Application pending·0 cites
- 1648US2005192345A1Crystalline polymorphs of a CXC-chemokine receptor ligandSCHERING CORP·Filed 2005·Application pending·0 cites
- 1747US2010249411A1Stereoselective Alkylation of Chiral 2-Methly-4 Protected PiperazinesWU WENXUE·Filed 2010·Application pending·0 cites
- 1846US6872826B2Stereoselective alkylation of chiral 2-methyl-4-protected piperazinesSCHERING CORP·Filed 2003·Granted Mar 29, 2005·0 cites·24 claims
- 1943US8519168B2Process and intermediates for the synthesis of 1,2-substituted 3,4-dioxo-1-cyclobutene compoundsFU XIAOYONG·Filed 2008·Granted Aug 27, 2013·0 cites·24 claims
- 2043US7985860B2Process and intermediates for the synthesis of 2-(quinolin-5-yl)-4,5 disubstituted-azole derivativesSCHERING CORP·Filed 2007·Granted Jul 26, 2011·0 cites·12 claims
- 2136US5283359AProcess for preparing albuterol, acetal, hemi-acetal, and hydrates of arylglyoxal intermediates thereofSCHERING CORP·Filed 1991·Granted Feb 1, 1994·1 cites·14 claims
- 2233US2002049350A1Process for preparing thrombin receptor antagonist building blocksFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →